Patterns of circulating inflammatory biomarkers in older persons with varying levels of physical performance: A partial least squares-discriminant analysis approach

Frontiers in Medicine

Volumn 1, Issue SEP, 2014, Pages

  Marzetti, Emanuele ^a   Landi, Francesco ^a   Marini, Federico ^b   Cesari, Matteo ^c,d   Buford, Thomas W ^e   Manini, Todd M ^e   Onder, Graziano ^a   Pahor, Marco ^e   Bernabei, Roberto ^a   Leeuwenburgh, Christiaan ^e   Calvani, Riccardo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c TOULOUSE UNIVERSITY HOSPITAL   (France)

^d UNIVERSITÉ PAUL SABATIER   (France)

^e UNIVERSITY OF FLORIDA   (United States)

Author keywords

Aging; Cytokines; Disability; Gait speed; Immune senescence; Inflammaging; Interleukin; Multiplex assay

Indexed keywords

EID: 84961591664     PISSN: None     EISSN: 2296858X     Source Type: Journal    
DOI: 10.3389/fmed.2014.00027     Document Type: Article

References (47)

1. Singh T, Newman AB. Inflammatory markers in population studies of aging. Ageing Res Rev (2011) 10:319-29. doi: 10.1016/j.arr.2010.11.002
2. Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci (2014) 69(Suppl 1):S4-9. doi:10.1093/gerona/glu057
3. Quinn TJ, McArthur K, Ellis G, Stott DJ. Functional assessment in older people. BMJ (2011) 343:d4681. doi:10.1136/bmj.d4681
4. Cesari M. Role of gait speed in the assessment of older patients. JAMA (2011) 305:93-4. doi:10.1001/jama.2010.1970
5. Elbaz A, Ripert M, Tavernier B, Février B, Zureik M, Gariépy J, et al. Common carotid artery intima-media thickness, carotid plaques, and walking speed. Stroke (2005) 36:2198-202. doi:10.1161/01.STR.0000181752.16915.5c
6. Cesari M, Onder G, Russo A, Zamboni V, Barillaro C, Ferrucci L, et al. Comorbidity and physical function: results from the aging and longevity study in the Sirente geographic area (ilSIRENTE study). Gerontology (2006) 52:24-32. doi:10.1159/000089822
7. Cesari M, Kritchevsky SB, Penninx BW, Nicklas BJ, Simonsick EM, Newman AB, et al. Prognostic value of usual gait speed in well-functioning older people-results from the Health, Aging and Body Composition Study. J Am Geriatr Soc (2005) 53:1675-80. doi:10.1111/j.1532-5415.2005.53501.x
8. Abellan van Kan G, Rolland Y, Andrieu S, Bauer J, Beauchet O, Bonnefoy M, et al. Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force. J Nutr Health Aging (2009) 13:881-9. doi:10.1007/s12603-009-0246-z
9. Afilalo J, Eisenberg MJ, Morin JF, Bergman H, Monette J, Noiseux N, et al. Gait speed as an incremental predictor of mortality and major morbidity in elderly patients undergoing cardiac surgery. J Am Coll Cardiol (2010) 56:1668-76. doi:10.1016/j.jacc.2010.06.039
10. Studenski S, Perera S, Patel K, Rosano C, Faulkner K, Inzitari M, et al. Gait speed and survival in older adults. JAMA (2011) 305:50-8. doi:10.1001/jama.2010.1923
11. Peel NM, Kuys SS, Klein K. Gait speed as a measure in geriatric assessment in clinical settings: a systematic review. J Gerontol A Biol Sci Med Sci (2013) 68:39-46. doi:10.1093/gerona/gls174
12. Franceschi C, Bonafè M, Valensin S, Olivieri F, De Luca M, Ottaviani E, et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci (2000) 908:244-54. doi:10.1111/j.1749-6632.2000.tb06651.x
13. Vasto S, Candore G, Balistreri CR, Caruso M, Colonna-Romano G, Grimaldi MP, et al. Inflammatory networks in ageing, age-related diseases and longevity. Mech Ageing Dev (2007) 128:83-91. doi:10.1016/j.mad.2006.11.015
14. Taaffe DR, Harris TB, Ferrucci L, Rowe J, Seeman TE. Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur studies of successful aging. J Gerontol A Biol Sci Med Sci (2000) 55:M709-15. doi:10.1093/gerona/55.12.M709
15. Cesari M, Penninx BW, Pahor M, Lauretani F, Corsi AM, Rhys Williams G, et al. Inflammatory markers and physical performance in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci (2004) 59:242-8. doi:10.1093/gerona/59.3.M242
16. Penninx BW, Kritchevsky SB, Newman AB, Nicklas BJ, Simonsick EM, Rubin S, et al. Inflammatory markers and incident mobility limitation in the elderly. J Am Geriatr Soc (2004) 52:1105-13. doi:10.1111/j.1532-5415.2004.52308.x
17. Verghese J, Holtzer R, Oh-Park M, Derby CA, Lipton RB, Wang C. Inflammatory markers and gait speed decline in older adults. J Gerontol A Biol Sci Med Sci (2011) 66:1083-9. doi:10.1093/gerona/glr099
18. Adriaensen W, Matheï C, van Pottelbergh G, Vaes B, Legrand D, Wallemacq P, et al. Significance of serum immune markers in identification of global functional impairment in the oldest old: cross-sectional results from the BELFRAIL study. Age (Dordr) (2014) 36:457-67. doi:10.1007/s11357-013-9558-3
19. Roubenoff R. The "cytokine for gerontologists" has some company. J Gerontol A Biol Sci Med Sci (2014) 69:163-4. doi:10.1093/gerona/glt184
20. Bandeen-Roche K, Walston JD, Huang Y, Semba RD, Ferrucci L. Measuring systemic inflammatory regulation in older adults: evidence and utility. Rejuvenation Res (2009) 12:403-10. doi:10.1089/rej.2009.0883
21. Hsu FC, Kritchevsky SB, Liu Y, Kanaya A, Newman AB, Perry SE, et al. Association between inflammatory components and physical function in the health, aging, and body composition study: a principal component analysis approach. J Gerontol A Biol Sci Med Sci (2009) 64:581-9. doi:10.1093/gerona/glp005
22. Morrisette-Thomas V, Cohen AA, Fülöp T, Riesco E, Legault V, Li Q, et al. Inflamm-aging does not simply reflect increases in pro-inflammatory markers. Mech Ageing Dev (2014) 139:49-57. doi:10.1016/j.mad.2014.06.005
23. Varadhan R, Yao W, Matteini A, Beamer BA, Xue QL, Yang H, et al. Simple biologically informed inflammatory index of two serum cytokines predicts 10 year all-cause mortality in older adults. J Gerontol A Biol Sci Med Sci (2014) 69:165-73. doi:10.1093/gerona/glt023
24. Buford TW, Lott DJ, Marzetti E, Wohlgemuth SE, Vandenborne K, Pahor M, et al. Age-related differences in lower extremity tissue compartments and associations with physical function in older adults. Exp Gerontol (2012) 47:38-44. doi:10.1016/j.exger.2011.10.001
25. Joseph AM, Adhihetty PJ, Buford TW, Wohlgemuth SE, Lees HA, Nguyen LM, et al. The impact of aging on mitochondrial function and biogenesis pathways in skeletal muscle of sedentary high-and low-functioning elderly individuals. Aging Cell (2012) 11:801-9. doi:10.1111/j.1474-9726.2012.00844.x
26. Marzetti E, Lees HA, Manini TM, Buford TW, Aranda JM Jr., Calvani R, et al. Skeletal muscle apoptotic signaling predicts thigh muscle volume and gait speed in community-dwelling older persons: an exploratory study. PLoS One (2012) 7:e32829. doi:10.1371/journal.pone.0032829
27. Guralnik JM, Ferrucci L, Pieper CF, Leveille SG, Markides KS, Ostir GV, et al. Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J Gerontol A Biol Sci Med Sci (2000) 55:M221-31. doi:10.1093/gerona/55.4.M221
28. Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol (1994) 49:M85-94. doi:10.1093/geronj/49.2.M85
29. Barker M, Rayens W. Partial least squares for discrimination. J Chemom (2003) 17:166-73. doi:10.1002/cem.785
30. Wold S, Martens H, Wold H. The multivariate calibration problem in chemistry solved by the PLS method. In: Kågström B, Ruhe A, editors. Matrix Pencils. Proceedings of a Conference Held at Pite Havsbad, Sweden, March 22-24, 1982. Lecture Notes in Mathematics. (Vol. 973), Heidelberg: Springer Verlag (1983). p. 286-93
31. Wold S, Johansson E, Cocchi M. PLS: partial least squares projections to latent structures. In: Kubinyi H, editor. 3D QSAR in Drug Design: Theory, Methods and Applications. Leiden: ESCOM Science Publishers (1993). p. 523-50
32. Westerhuis JA, Hoefsloot HCJ, Smit S, Vis DJ, Smilde AK, van Velzen EJJ, et al. Assessment of PLS-DA cross-validation. Metabolomics (2008) 4:81-9. doi:10.1007/s11306-007-0099-6
33. Szymanska E, Saccenti E, Smilde AK, Westerhuis JA. Double-check: validation of diagnostic statistics for PLS-DA models in metabolomics studies. Metabolomics (2012) 8(Suppl 1):3-16. doi:10.1007/s11306-011-0330-3
34. Westerhuis JA, van Velzen EJJ, Hoefsloot HCJ, Smilde AK. Discriminant Q2 (DQ2) for improved discrimination in PLSDA models. Metabolomics (2008) 4:293-6. doi:10.1007/s11306-008-0126-2
35. Ferrucci L, Penninx BW, Volpato S, Harris TB, Bandeen-Roche K, Balfour J, et al. Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geriatr Soc (2002) 50:1947-54. doi:10.1046/j.1532-5415.2002.50605.x
36. Tiainen K, Hurme M, Hervonen A, Luukkaala T, Jylhä M. Inflammatory markers and physical performance among nonagenarians. J Gerontol A Biol Sci Med Sci (2010) 65:658-63. doi:10.1093/gerona/glq056
37. Aderem A, Smith KD. A systems approach to dissecting immunity and inflammation. Semin Immunol (2004) 16:55-67. doi:10.1016/j.smim.2003.10.002
38. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol (1994) 55:97-179. doi:10.1016/S0065-2776(08)60509-X
39. Zhang J, Alcaide P, Liu L, Sun J, He A, Luscinskas FW, et al. Regulation of endothelial cell adhesion molecule expression by mast cells, macrophages, and neutrophils. PLoS One (2011) 6:e14525. doi:10.1371/journal.pone.0014525
40. Fujishima S, Hoffman AR, Vu T, Kim KJ, Zheng H, Daniel D, et al. Regulation of neutrophil interleukin 8 gene expression and protein secretion by LPS, TNF-alpha, and IL-1 beta. J Cell Physiol (1993) 154:478-85. doi:10.1002/jcp.1041540305
41. Wright HL, Moots RJ, Bucknall RC, Edwards SW. Neutrophil function in inflammation and inflammatory diseases. Rheumatology (Oxford) (2010) 49:1618-31. doi:10.1093/rheumatology/keq045
42. Keshari RS, Jyoti A, Dubey M, Kothari N, Kohli M, Bogra J, et al. Cytokines induced neutrophil extracellular traps formation: implication for the inflammatory disease condition. PLoS One (2012) 7:e48111. doi:10.1371/journal.pone.0048111
43. Beenakker KG, Westendorp RG, de Craen AJ, Slagboom PE, van Heemst D, Maier AB. Pro-inflammatory capacity of classically activated monocytes relates positively to muscle mass and strength. Aging Cell (2013) 12:682-9. doi:10.1111/acel.12095
44. Tedder TF, Steeber DA, Chen A, Engel P. The selectins: vascular adhesion molecules. FASEB J (1995) 9:866-73. doi:10.1096/fj.1530-6860
45. Ridker PM, Buring JE, Rifai N. Soluble P-selectin and the risk of future cardiovascular events. Circulation (2001) 103:491-5. doi:10.1161/01.CIR.103.4.491
46. Barbaux SC, Blankenberg S, Rupprecht HJ, Francomme C, Bickel C, Hafner G, et al. Association between P-selectin gene polymorphisms and soluble P-selectin levels and their relation to coronary artery disease. Arterioscler Thromb Vasc Biol (2001) 21:1668-73. doi:10.1161/hq1001.097022
47. Wong CS, Gamble JR, Skinner MP, Lucas CM, Berndt MC, Vadas MA. Adhesion protein GMP140 inhibits superoxide anion release by human neutrophils. Proc Natl Acad Sci U S A (1991) 88:2397-401. doi:10.1073/pnas.88.6.2397